Lineage Cell Therapeutics In shares owned by Broadwood Capital
Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Broadwood Capital
from 13F filings
Historical chart of Broadwood Capital investment in Lineage Cell Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including Lineage Cell Therapeutics In held by Broadwood Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lineage Cell Therapeutics In by Broadwood Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $84M | 50M | 1.69 |
| 2025-06-30 | $45M | 50M | 0.91 |
| 2025-03-31 | $22M | 50M | 0.45 |
| 2024-12-31 | $21M | 42M | 0.50 |
| 2024-09-30 | $38M | 42M | 0.91 |
| 2024-06-30 | $42M | 42M | 1.00 |
| 2024-03-31 | $62M | 42M | 1.48 |
| 2023-12-31 | $38M | 35M | 1.09 |
| 2023-09-30 | $41M | 35M | 1.18 |
| 2023-06-30 | $49M | 35M | 1.41 |
| 2023-03-31 | $52M | 35M | 1.50 |
| 2022-12-31 | $41M | 35M | 1.17 |
| 2022-09-30 | $40M | 35M | 1.13 |
| 2022-06-30 | $55M | 35M | 1.58 |
| 2022-03-31 | $54M | 35M | 1.54 |
| 2021-12-31 | $83M | 34M | 2.45 |
| 2021-09-30 | $86M | 34M | 2.52 |
| 2021-06-30 | $97M | 34M | 2.85 |
| 2021-03-31 | $80M | 34M | 2.35 |
| 2020-12-31 | $60M | 34M | 1.76 |
| 2020-09-30 | $32M | 34M | 0.94 |
| 2020-06-30 | $30M | 34M | 0.87 |
| 2020-03-31 | $28M | 34M | 0.83 |
| 2019-12-31 | $30M | 34M | 0.89 |
| 2019-09-30 | $33M | 34M | 0.98 |